Biotransformation and brain distribution of the anti-COVID-19 drug molnupiravir and herb-drug pharmacokinetic interactions between the herbal extract Scutellaria formula-NRICM101
Authors:
- 30 May 2023
- journal article
- research article
- Published by Elsevier in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 234, 115499
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Characterization of orally efficacious influenza drug with high resistance barrier in ferrets and human airway epitheliaScience Translational Medicine, 2019
- Utility of the carboxylesterase inhibitorbis-para-nitrophenylphosphate (BNPP) in the plasma unbound fraction determination for a hydrolytically unstable amide derivative and agonist of the TGR5 receptorXenobiotica, 2010
- Pharmacological effects of a novel isosorbide-based butyrylcholinesterase inhibitorChemico-Biological Interactions, 2008
- Structure and Catalytic Properties of Carboxylesterase Isozymes Involved in Metabolic Activation of ProdrugsMolecules, 2008
- Dose translation from animal to human studies revisitedThe FASEB Journal, 2007
- Carboxylesterase in the liver and small intestine of experimental animals and humanLife Sciences, 2007
- Current Progress on Esterases: From Molecular Structure to FunctionDrug Metabolism and Disposition, 2002
- Effect of P‐glycoprotein modulators on the pharmacokinetics of camptothecin using microdialysisBritish Journal of Pharmacology, 2001
- Pharmacokinetics of pefloxacin and its interaction with cyclosporin A, a P‐glycoprotein modulator, in rat blood, brain and bile, using simultaneous microdialysisBritish Journal of Pharmacology, 2001
- Inhibition of phenacetin- and acetanilide-induced methemoglobinemia in the rat by the carboxylesterase inhibitor Bis-[p-nitrophenyl] phosphateBiochemical Pharmacology, 1969